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Methods for interpreting verbal autopsy (VA) that have
been validated fall into two major categories: (1) physi-
cian-certified verbal autopsy (PCVA), the commonly-
used method in which one or more physicians ascertain
causes of death based on their clinical judgment; and (2)
computerized coding of verbal autopsy (CCVA), in
which causes of death are derived using predefined cri-
teria. Decision rules for CCVA can be expert opinion-
based or data driven. The accuracy of these VA inter-
pretation methods varies depending on causes of death
per se, while the effect of misclassification error in VA
on the estimates of cause-specific mortality fractions
(CSMF) depends on the distribution of causes of death.
The importance of acknowledging the effects of misclas-
sification of causes of death by VA has been highlighted
by the recent controversial estimates of malaria mortal-
ity in India [1]. The parameters of validity of VA
obtained from a validation study may be useful to mea-
sure the uncertainty limits of CSMFs due to misclassifi-
cation errors of VA, and in some contexts, to adjust the
estimate of CSMF for the effect of misclassification
error [2,3].
The gold standard diagnosis of cause of death (COD)
for assessing the validity of VA has been the COD
derived from hospital medical records. The main limita-
tions of using hospital-based CODs as the gold standard
are: (1) The accuracy of medical records-based COD is
debatable, even though some studies have refined the
diagnosis with expert review of hospital records; and (2)
the composition and distribution of hospital CODs may
not be representative of deaths occurring in the commu-
nity. In addition, if diagnostic algorithms for CCVA are
developed from subsets of validation study datasets,
their external validity may be compromised. Neverthe-
less, hospital diagnosis of COD based on defined clinical
and laboratory criteria are the only useful gold standard
available at present for validating VAs.
The validity of InterVA has not previously been tested
against a gold standard diagnosis. The reliability of
InterVA has been determined by examining the concor-
dance of CSMFs estimated by InterVA and PCVA.
Given that the accuracy of PCVA is questionable, esti-
mating concordance between causes of death derived by
PCVA and InterVA as a measure of validity needs to be
interpreted with caution.
Measures used to assess the validity of VA include
sensitivity, specificity, positive predictive value, and
absolute (absolute error) or relative (relative error) dif-
ference between CSMF estimated by VA and true
CSMF in the validation data. Sensitivity and specificity
that measure accuracy at the individual level vary sub-
stantially between causes of death across different VA
interpretation methods. The absolute and relative errors
of CSMF measure the accuracy of VA at the population
level. The variability of the absolute error in CSMF
appears to be reasonable for most CODs because often
the number of false positive and false negative diagnoses
balance out. However, the relative error in CSMF tends
to be exaggerated, especially if the CSMF is low.
Murray and colleagues in this series recommend
determining the validity of VAs using cause-specific and
average chance-corrected concordance across causes for
single cause assignment methods, as well as for one to k
causes across causes for individual multiple cause
assignment methods [4]. For estimation of CSMFs, they
recommend CSMF accuracy and cause-specific concor-
dance correlation coefficients of estimated CSMFs com-
pared to true CSMFs. These measures are useful to
compare the performance of different VA interpretation
methods and could also be used to estimate the uncer-
tainty limits of CSMF estimates attributable to misclassi-
fication errors of VA. Methods to estimate uncertainty
limits for CSMFs attributable to misclassification errors
of VA need to be further developed. Correspondence: Daniel.chandramohan@lshtm.ac.uk
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CCVA, the Random Forest (RF) Method, for interpret-
ing VA in a large multicountry validation dataset. The
median chance corrected concordance rate of the RF
Method is higher than PCVA for adult, child, and neo-
natal VAs. These are very promising results and if con-
firmed in other validation datasets, software for coding
VAs based on the RF Method would greatly improve
the reliability and timeliness of CSMFs collected using
VAs. What is urgently required is an objective assess-
ment of the performance of the RF Method versus
InterVA, based on this high-standard VA validation
study dataset, and then to actively promote and facilitate
the implementation of the best-performing method in
all mortality surveillance systems using VAs. This would
likely greatly improve the quality and comparability of
cause-specific mortality data obtained using VAs.
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